Development of an inflammation imaging tracer, 111 In-DOTA-DAPTA, targeting chemokine receptor CCR5 and preliminary evaluation in an ApoE −/− atherosclerosis mouse model

Conclusion111In-DOTA-DAPTA, specifically targeting chemokine receptor CCR5, is a potential SPECT agent for imaging inflammation in atherosclerosis.

Source: Journal of Nuclear Cardiology - February 7, 2018 Category: Nuclear Medicine Source Type: research